6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-amine, 250mg

Methyl 2-bromo-5-(trifluoromethyl)benzoate, 95.0%, 1g

3-Acetylphenylboronic acid, 97.0%, 10g

4-(4-METHYLTHIAZOL-5-YL)BENZONITRILE, 95.0%, 1g

2-Bromo-4-chloro-6-fluorotoluene, 1g

5,6-Dihydro-4H-pyrrolo[3,4-d]thiazole hydrochloride, 98+%, 100mg

(R)-4-N-Boc-2-hydroxymethyl-piperazine, 95.0%, 5g

3-Methyl-4-isopropylaniline hydrochloride, 95%, 100g

3-(Dimethylamino)benzoic Acid>98.0%(GC)(T)25g

CDTA, min. 99%, for synthesis, 250 g, plastic packaging.

2-Trifluoromethylphenylsulfonylethanol, 98.0%, 5g

Ethyl 2-(methylamino)benzoate, 95.0%, 1g

2-Hydroxy-4-methyl-nicotinic acid, 95.0%, 100mg